Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with an unknown etiology and currently few effective therapies. Immune system alterations have being demonstrated in ASD, both in humans and via animal models; immune imbalance thus arises as a possible pathway for drug intervention. In this review, the studies were classified into 2 major groups: (1) clinical research whose authors classify therapies with primary anti-inflammatory and immunomodulatory actions, making use of: sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, flavonoid luteolin, corticosteroids, oral immunoglobulin, intravenous immunoglobulin, cell therapy, dialyzable lymphocyte extracts, minocycline, and pioglitazone; and (2) other ASD therapies already used or currently under study whose initial characteristics were neither anti-inflammatory nor immunomodulatory initially, but displayed a capacity for immunomodulation throughout the treatment: risperidone, vitamin D, omega-3, Ginkgo biloba, L-carnosine, N-acetylcysteine, and microbiome restoration. These studies used various data acquisition methodologies. Questions arose such the need for randomized and placebo-controlled studies with greater numbers of participants as well as the use of biomarkers to refine the treatment of autistic subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, studies in human and animal models indicate immunological dysfunction in ASD (61), while recent research highlights the co-ocurrence of mast cell dysregulation in EDS (62, 63) suggesting problems in the immune system.”
From Autism, joint hypermobility-related disorders and pain (2018) · cites this paper as [61]
Citations
Cites
1 retracted
Saad, K., Abdel‐Rahman, A. A., Elserogy, Y. M., Al‐Atram, A. A., El‐Houfey, A. A., Othman, H. A. K., Bjørklund, G., Jia, F., Urbina, M. A., Abo‐Elela, M. G. M., et al. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12652 · Cited by 99
RetractedMiddleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
The epidemiology and global burden of autism spectrum disorders
Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheurer, R. W., Vos, T., & Scott, J. G. (2015) · Psychological Medicine · doi:10.1017/s003329171400172x · Cited by 1,224
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Juge, N., Mithen, R. F., & Traka, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6484-5 · Cited by 693
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613
Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b76658 · Cited by 566
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
Masi, A., Quintana, D. S., Glozier, N., Lloyd, A. R., Hickie, I. B., & Guastella, A. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.59 · Cited by 466
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Sulforaphane treatment of autism spectrum disorder (ASD)
Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416940111 · Cited by 449
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., & Iyengar, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300627 · Cited by 408
Eicosapentaenoic Acid Prevents LPS-Induced TNF-α Expression by Preventing NF-κB Activation
Zhao, Y., Joshi-Barve, S., Barve, S., & Chen, L. H. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719345 · Cited by 405
Pärtty, A., Kalliomäki, M., Wacklin, P., Salminen, S., & Isolauri, E. (2015) · Pediatric Research · doi:10.1038/pr.2015.51 · Cited by 397
Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Cao, J., Papadopoulou, N., Cetrulo, C. L., & Theoharides, T. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706246 · Cited by 336
Leigh, M. J. S., Nguyen, D. V., Mu, Y., Winarni, T. I., Schneider, A., Chechi, T., Polussa, J., Doucet, P., Tassone, F., Rivera, S. M., et al. (2013) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318287cd17 · Cited by 298
A randomized controlled pilot trial of oral N-acetylcysteine in children with autism
Hardan, A. Y., Fung, L. K., Libove, R. A., Obukhanych, T. V., Nair, S., Herzenberg, L. A., Frazier, T. W., & Tirouvanziam, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.014 · Cited by 293
Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases
Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., & Hrelia, P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/415078 · Cited by 282
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279
Ashwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R. L., Croen, L. A., Ozonoff, S., Pessah, I. N., & de Water, J. V. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.006 · Cited by 271
The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder
Masi, A., Glozier, N., Dale, R., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0103-8 · Cited by 260
The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder
Li, Q., & Zhou, J.-M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.013 · Cited by 253
Saad, K., Abdel-rahman, A. A., Elserogy, Y. M., Al-Atram, A. A., Cannell, J. J., Bjørklund, G., Abdel-Reheim, M. K., Othman, H. A. K., El-Houfey, A. A., Abd El-Aziz, N. H. R., et al. (2016) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000019 · Cited by 244
Taliou, A., Zintzaras, E., Lykouras, L., & Francis, K. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.006 · Cited by 233
Weiss, J. A., Cappadocia, M. C., MacMullin, J. A., Viecili, M., & Lunsky, Y. (2012) · Autism · doi:10.1177/1362361311422708 · Cited by 228
Hollander, E., Soorya, L., Chaplin, W., Anagnostou, E., Taylor, B. P., Ferretti, C. J., Wasserman, S., Swanson, E., & Settipani, C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10050764 · Cited by 224
Open-label add-on treatment trial of minocycline in fragile X syndrome.
Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M., & Ethell, D. W. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-91 · Cited by 223
Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302611 · Cited by 221
Chez, M. G., Buchanan, C. P., Aimonovitch, M. C., Becker, M., Schaefer, K., Black, C., & Komen, J. (2002) · Journal of Child Neurology · doi:10.1177/08830738020170111501 · Cited by 220
Naltrexone in autistic children: Behavioral symptoms and attentional learning
CAMPBELL, M., ANDERSON, L. T., SMALL, A. M., ADAMS, P., GONZALEZ, N. M., & ERNST, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199311000-00024 · Cited by 210
Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism
Karvat, G., & Kimchi, T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.274 · Cited by 204
Jyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005) · Neuropsychobiology · doi:10.1159/000084164 · Cited by 201
A Pilot Study of d-Cycloserine in Subjects With Autistic Disorder
Posey, D. J., Kem, D. L., Swiezy, N. B., Sweeten, T. L., Wiegand, R. E., & McDougle, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2115 · Cited by 199
Tsilioni, I., Taliou, A., Francis, K., & Theoharides, T. C. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.142 · Cited by 199
KING, B. H., WRIGHT, D. M., HANDEN, B. L., SIKICH, L., ZIMMERMAN, A. W., MCMAHON, W., CANTWELL, E., DAVANZO, P. A., DOURISH, C. T., DYKENS, E. M., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00010 · Cited by 196
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Elevated serum levels of interleukin-17A in children with autism
AL-Ayadhi, L. Y., & Mostafa, G. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-158 · Cited by 193
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms
Heuer, L., Ashwood, P., Schauer, J., Goines, P., Krakowiak, P., Hertz‐Picciotto, I., Hansen, R., Croen, L. A., Pessah, I. N., & Van de Water, J. (2008) · Autism Research · doi:10.1002/aur.42 · Cited by 190
The level of arabinitol in autistic children after probiotic therapy
Kałużna-Czaplińska, J., & Błaszczyk, S. (2012) · Nutrition · doi:10.1016/j.nut.2011.08.002 · Cited by 189
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 189
Leng, Y., & Chuang, D.-M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0096-06.2006 · Cited by 188
Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4044-5 · Cited by 183
Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human Macrophages
Ariasnegrete, S., Keller, K., & Chadee, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1378 · Cited by 181
Rosenblat, J. D., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.042 · Cited by 178
Lv, Y.-T., Zhang, Y., Liu, M., Qiuwaxi, J.-N.-T., Ashwood, P., Cho, S. C., Huan, Y., Ge, R.-C., Chen, X.-W., Wang, Z.-J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-196 · Cited by 174
Mostafa, G. A., & AL-Ayadhi, L. Y. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-201 · Cited by 168
Altered Cytokine and BDNF Levels in Autism Spectrum Disorder
Ricci, S., Businaro, R., Ippoliti, F., Lo Vasco, V. R., Massoni, F., Onofri, E., Troili, G. M., Pontecorvi, V., Morelli, M., Rapp Ricciardi, M., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9393-4 · Cited by 167
Autism spectrum disorders: an overview on diagnosis and treatment
Brentani, H., Paula, C. S. D., Bordini, D., Rolim, D., Sato, F., Portolese, J., Pacifico, M. C., & McCracken, J. T. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2013-s104 · Cited by 166
Evidence supporting an altered immune response in ASD
Mead, J., & Ashwood, P. (2015) · Immunology Letters · doi:10.1016/j.imlet.2014.11.006 · Cited by 165
Derosa, G., Sahebkar, A., & Maffioli, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25804 · Cited by 165
STEINGARD, R. J., ZIMNITZKY, B., DeMASO, D. R., BAUMAN, M. L., & BUCCI, J. P. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.9 · Cited by 164
Novel and Emerging Treatments for Autism Spectrum Disorders: A Systematic Review
Rossignol, D. A. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100404 · Cited by 162
Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages
Palacio, J. R., Markert, U. R., & Martínez, P. (2011) · Inflammation Research · doi:10.1007/s00011-011-0323-8 · Cited by 160
Willemsen-Swinkels, S. H. N. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950210060011 · Cited by 159
Immune Dysfunction in Autism: A Pathway to Treatment
Careaga, M., Van de Water, J., & Ashwood, P. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.003 · Cited by 159
Yessoufou, A., & Wahli, W. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13071 · Cited by 154
Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in egyptian children with autism
Meguid, N. A., Hashish, A. F., Anwar, M., & Sidhom, G. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0349 · Cited by 154
Ghanizadeh, A., & Moghimi-Sarani, E. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-196 · Cited by 152
Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 151
Pharmacological therapies for autism spectrum disorder: a review.
(2015) · PubMed Central · Cited by 150
Resveratrol prevents social deficits in animal model of autism induced by valproic acid
Bambini-Júnior, V., Zanatta, G., Nunes, G. D., de Melo, G. M., Michels, M., Fontes‐Dutra, M., Freire, V. N., Riesgo, R. D. S., & Gottfried, C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.09.039 · Cited by 146
Self-citationCore Symptoms of Autism Improved After Vitamin D Supplementation
Jia, F., Wang, B., Shan, L., Xu, Z., Staal, W. G., & Du, L. (2015) · Pediatrics · doi:10.1542/peds.2014-2121 · Cited by 145
Mazahery, H., Stonehouse, W., Delshad, M., Kruger, M., Conlon, C., Beck, K., & Von Hurst, P. (2017) · Nutrients · doi:10.3390/nu9020155 · Cited by 144
The Impact of Neuroimmune Alterations in Autism Spectrum Disorder
Gottfried, C., Bambini-Junior, V., Francis, F., Riesgo, R., & Savino, W. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00121 · Cited by 143
Self-citationImmune Endophenotypes in Children With Autism Spectrum Disorder
Careaga, M., Rogers, S., Hansen, R. L., Amaral, D. G., Van de Water, J., & Ashwood, P. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.036 · Cited by 143
Madore, C., Leyrolle, Q., Lacabanne, C., Benmamar-Badel, A., Joffre, C., Nadjar, A., & Layé, S. (2016) · Neural Plasticity · doi:10.1155/2016/3597209 · Cited by 141
Targeting gut microbiome: a novel and potential therapy for autism
Yang, Y., Tian, J., & Yang, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.027 · Cited by 140
Wu, H., Wang, X., Gao, J., Liang, S., Hao, Y., Sun, C., Xia, W., Cao, Y., & Wu, L. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.01.012 · Cited by 139
Nutritional and Dietary Interventions for Autism Spectrum Disorder: A Systematic Review
Sathe, N., Andrews, J. C., McPheeters, M. L., & Warren, Z. E. (2017) · PEDIATRICS · doi:10.1542/peds.2017-0346 · Cited by 138
Dawson, G., Sun, J. M., Davlantis, K. S., Murias, M., Franz, L., Troy, J. D., Simmons, R., Sabatos‐DeVito, M., Durham, R., & Kurtzberg, J. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0474 · Cited by 136
Immune dysregulation in autism spectrum disorder
Noriega, D. B., & Savelkoul, H. F. J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2183-4 · Cited by 135
Autoantibodies to cerebellum in children with autism associate with behavior
Goines, P., Haapanen, L., Boyce, R., Duncanson, P., Braunschweig, D., Delwiche, L., Hansen, R., Hertz-Picciotto, I., Ashwood, P., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.017 · Cited by 134
Sertraline in Adults With Pervasive Developmental Disorders: A Prospective Open-Label Investigation
McDougle, C. J., Brodkin, E. S., Naylor, S. T., Carlson, D. C., Cohen, D. J., & Price, L. H. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00010 · Cited by 132
Gut Microbiota, Inflammation, and Probiotics on Neural Development in Autism Spectrum Disorder
Doenyas, C. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.060 · Cited by 131
Brief report: A double-blind study of naltrexone in infantile autism
Leboyer, M., Bouvard, M. P., Launay, J.-M., Tabuteau, F., Waller, D., Dugas, M., Kerdelhue, B., Lensing, P., & Panksepp, J. (1992) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01058158 · Cited by 130
Effect of pioglitazone treatment on behavioral symptoms in autistic children.
Boris, M., Kaiser, C. C., Goldblatt, A., Elice, M. W., Edelson, S. M., Adams, J. B., & Feinstein, D. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-3 · Cited by 129
Use of Carnosine for Oxidative Stress Reduction in Different Pathologies
Prokopieva, V. D., Yarygina, E. G., Bokhan, N. A., & Ivanova, S. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2939087 · Cited by 129
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
Jasion, V. S., & Burnett, B. P. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0010-7 · Cited by 123
Naltrexone in Young Autistic Children: A Double-Blind, Placebo-Controlled Crossover Study
Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199502000-00018 · Cited by 122
A Case Series of a Luteolin Formulation (Neuroprotek®) in Children with Autism Spectrum Disorders
Theoharides, T. C., Asadi, S., & Panagiotidou, S. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500201 · Cited by 120
Wink, L. K., Adams, R., Wang, Z., Klaunig, J. E., Plawecki, M. H., Posey, D. J., McDougle, C. J., & Erickson, C. A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0088-6 · Cited by 117
Kim, J.-W., Seung, H., Kwon, K. J., Ko, M. J., Lee, E. J., Oh, H. A., Choi, C. S., Kim, K. C., Gonzales, E. L., You, J. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104927 · Cited by 115
Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages
Allam-Ndoul, B., Guénard, F., Barbier, O., & Vohl, M.-C. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0241-4 · Cited by 115
Akhondzadeh, S., Fallah, J., Mohammadi, M.-R., Imani, R., Mohammadi, M., Salehi, B., Ghanizadeh, A. J., Raznahan, M., Mohebbi-Rasa, S., Rezazadeh, S., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.012 · Cited by 114
MacDowell, K. S., García-Bueno, B., Madrigal, J. L. M., Parellada, M., Arango, C., Micó, J. A., & Leza, J. C. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001775 · Cited by 114
Owley, T., Salt, J., Guter, S., Grieve, A., Walton, L., Ayuyao, N., Leventhal, B. L., & Cook, E. H. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.517 · Cited by 113
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.
Barrett, R. P., Feinstein, C., & Hole, W. T. (1989) · PubMed · Cited by 112
Bouvard, M. P., Leboyer, M., Launay, J.-M., Recasens, C., Plumet, M.-H., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P., et al. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02601-r · Cited by 112
Chugani, D. C., Chugani, H. T., Wiznitzer, M., Parikh, S., Evans, P. A., Hansen, R. L., Nass, R., Janisse, J. J., Dixon-Thomas, P., Behen, M., et al. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.033 · Cited by 112
Nikoo, M., Radnia, H., Farokhnia, M., Mohammadi, M.-R., & Akhondzadeh, S. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000063 · Cited by 112
Fluoxetine in Treatment of Adolescent Patients with Autism: A Longitudinal Open Trial
Fatemi, S. H., Realmuto, G. M., Khan, L., & THURAS, P. D. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026008602540 · Cited by 110
Behavioral Correlates of Maternal Antibody Status Among Children with Autism
Braunschweig, D., Duncanson, P., Boyce, R., Hansen, R., Ashwood, P., Pessah, I. N., Hertz-Picciotto, I., & Van de Water, J. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1378-7 · Cited by 110
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., Shetty, A., Mishra, P., Kali, M., Biju, H., et al. (2013) · Stem Cells International · doi:10.1155/2013/623875 · Cited by 110
Sertraline response in adults with mental retardation and autistic disorder.
Hellings, J. A., Kelley, L. A., Gabrielli, W. F., Kilgore, E., & Shah, P. (1996) · PubMed · Cited by 109
Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders
Bhandari, R., & Kuhad, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.012 · Cited by 106
Schneider, C. K., Melmed, R. D., Barstow, L. E., Enriquez, F. J., Ranger‐Moore, J., & Ostrem, J. A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0141-y · Cited by 105
Bertolino, B., Crupi, R., Impellizzeri, D., Bruschetta, G., Cordaro, M., Siracusa, R., Esposito, E., & Cuzzocrea, S. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12648 · Cited by 105
Bakheet, S. A., Alzahrani, M. Z., Ansari, M. A., Nadeem, A., Zoheir, K. M. A., Attia, S. M., AL-Ayadhi, L. Y., & Ahmad, S. F. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0066-1 · Cited by 101
An Open-Label Trial of Escitalopram in Pervasive Developmental Disorders
Owley, T. B., Walton, L., Salt, J., Guter, S. J., Winnega, M., LEVENTHAL, B. L., & Cook, E. H. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153229.80215.a0 · Cited by 100
Nierenberg, A. A., Ghaznavi, S., Mathias, I. S., Ellard, K. K., JANOS, J. A., & Sylvia, L. G. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.12.014 · Cited by 100
Case Study: Corticosteroid Treatment of Language Regression in Pervasive Developmental Disorder
Stefanatos, G. A., Grover, W. D., & Geller, E. T. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199508000-00022 · Cited by 97
Stubbs, E. G. (1976) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01543467 · Cited by 96
Toward an immune-mediated subtype of autism spectrum disorder
McDougle, C. J., Landino, S. M., Vahabzadeh, A., O’Rourke, J., Zurcher, N. R., Finger, B. C., Palumbo, M. L., Helt, J., Mullett, J. E., Hooker, J. M., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.048 · Cited by 95
Rütter, A., & Luger, T. A. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.112325 · Cited by 93
Intravenous Immunoglobulin Treatment of Children With Autism
Plioplys, A. V. (1998) · Journal of Child Neurology · doi:10.1177/088307389801300207 · Cited by 93
Peripheral Inflammatory Markers Contributing to Comorbidities in Autism
Inga Jácome, M., Morales Chacòn, L., Vera Cuesta, H., Maragoto Rizo, C., Whilby Santiesteban, M., Ramos Hernandez, L., Noris García, E., González Fraguela, M., Fernandez Verdecia, C., Vegas Hurtado, Y., et al. (2016) · Behavioral Sciences · doi:10.3390/bs6040029 · Cited by 93
Mechanisms of Glucocorticoids in the Control of Neuroinflammation
Schweingruber, N., Reichardt, S. D., Lühder, F., & Reichardt, H. M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02161.x · Cited by 89
Ferguson, B. J., Marler, S., Altstein, L. L., Lee, E. B., Mazurek, M. O., McLaughlin, A., Macklin, E. A., McDonnell, E., Davis, D. J., Belenchia, A. M., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.05.009 · Cited by 89
Piras, I. S., Haapanen, L., Napolioni, V., Sacco, R., Van de Water, J., & Persico, A. M. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.12.020 · Cited by 88
Suda, S., Katsura, K., Kanamaru, T., Saito, M., & Katayama, Y. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.020 · Cited by 85
Willemsen‐Swinkels, S. H. N., Buitelaar, J. K., & van Engeland, H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00297-9 · Cited by 85
Mostafa, G. A., & AL-ayadhi, L. Y. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-39 · Cited by 85
Jyonouchi, H., Geng, L., & Davidow, A. L. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0187-2 · Cited by 85
The Family Context of Autism Spectrum Disorders
Smith, L. E., Greenberg, J. S., & Mailick, M. R. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.08.006 · Cited by 83
THE SPIRONOLACTONE/ARTHRITIS STUDY GROUP, BENDTZEN, K., HANSEN, P. R., & RIENECK, K. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02249.x · Cited by 83
Brief Report: A Pilot Open Clinical Trial of Intravenous Immunoglobulin in Childhood Autism
DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cunningham‐Rundles, C., & Hollander, E. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1023096728131 · Cited by 79
Autism, will vitamin D treat core symptoms?
Cannell, J. J. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.05.004 · Cited by 79
B Lymphocyte Antigen D8/17 and Repetitive Behaviors in Autism
Hollander, E., DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cartwright, C., DeCaria, C. M., Kwon, J., Cunningham-Rundles, C., Chapman, F., & Zabriskie, J. B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.317 · Cited by 79
Lack of effect of vitamin D3supplementation in autism: a 20-week, placebo-controlled RCT
Kerley, C. P., Power, C., Gallagher, L., & Coghlan, D. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-312783 · Cited by 79
Naltrexone in autistic children: a double-blind and placebo-controlled study.
Campbell, M., Anderson, L. T., Small, A. M., Locascio, J. J., Lynch, N., & Choroco, M. C. (1990) · PubMed · Cited by 78
Immunological Treatments for Autism
Gupta, S. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005568027292 · Cited by 78
Sobiś, J., Rykaczewska-Czerwińska, M., Świętochowska, E., & Gorczyca, P. W. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.007 · Cited by 78
Sareddy, G. R., Geeviman, K., Ramulu, C., & Babu, P. P. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0662-x · Cited by 78
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Lacivita, E., Perrone, R., Margari, L., & Leopoldo, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00965 · Cited by 78
Ghaleiha, A., Rasa, S. M., Nikoo, M., Farokhnia, M., Mohammadi, M.-R., & Akhondzadeh, S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.043 · Cited by 77
Urbano, M., Okwara, L., Manser, P., Hartmann, K., Herndon, A., & Deutsch, S. I. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000033 · Cited by 76
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder
Napolioni, V., Ober-Reynolds, B., Szelinger, S., Corneveaux, J. J., Pawlowski, T., Ober-Reynolds, S., Kirwan, J., Persico, A. M., Melmed, R. D., Craig, D. W., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-38 · Cited by 76
Seki, Y., Kato, T. A., Monji, A., Mizoguchi, Y., Horikawa, H., Sato‐Kasai, M., Yoshiga, D., & Kanba, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.09.011 · Cited by 76
Dean, O. M., Gray, K. M., Villagonzalo, K.-A., Dodd, S., Mohebbi, M., Vick, T., Tonge, B. J., & Berk, M. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416652735 · Cited by 76
Naltrexone in Young Autistic Children: Replication Study and Learning Measures
Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(09)66567-9 · Cited by 74
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties
Ximenes, J. C. M., Gonçalves, D. D. O., Siqueira, R. M. P., Neves, K. R. T., Cerqueira, G. S., Correia, A. O., Felix, F. H. C., Leal, L. K. A. M., Brito, G. A. D. C., Naffah‐Mazzacoratti, M. D. G., et al. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0853-4 · Cited by 73
Phenotypic expression of Autoimmune Autistic Disorder (Aad): A Major subset of Autism
Singh, V. K. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100303 · Cited by 73
Minshawi, N. F., Wink, L. K., Shaffer, R., Plawecki, M. H., Posey, D. J., Liu, H., Hurwitz, S., McDougle, C. J., Swiezy, N. B., & Erickson, C. A. (2016) · Molecular Autism · doi:10.1186/s13229-015-0062-8 · Cited by 73
Hasanzadeh, E., Mohammadi, M.-R., Ghanizadeh, A. J., Rezazadeh, S., Tabrizi, M. H., Rezaei, F., & Akhondzadeh, S. (2012) · Child Psychiatry & Human Development · doi:10.1007/s10578-012-0292-3 · Cited by 72
A pharmacogenetic study of escitalopram in autism spectrum disorders
Owley, T., Brune, C. W., Salt, J., Walton, L., Guter, S., Ayuyao, N., Gibbons, R. D., Leventhal, B. L., & Cook, E. H. (2010) · Autism Research · doi:10.1002/aur.109 · Cited by 72
Pharmacotherapy of autism spectrum disorders
Benvenuto, A., Battan, B., Porfirio, M. C., & Curatolo, P. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.03.015 · Cited by 70
IMMUNOMODULATORY PROPERTIES OF PENTOXIFYLLINE ARE MEDIATED VIA ADENOSINE-DEPENDENT PATHWAYS
Kreth, S., Ledderose, C., Luchting, B., Weis, F. C., & Thiel, M. (2010) · Shock · doi:10.1097/shk.0b013e3181cdc3e2 · Cited by 70
Hirsch, M. M., Deckmann, I., Fontes‐Dutra, M., Bauer‐Negrini, G., Nunes, G. D., Nunes, W. S., Rabelo, B. F., Riesgo, R. D. S., Margis, R., Bambini-Júnior, V., et al. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.061 · Cited by 70
Self-citationNeuroglia in ageing and disease
Verkhratsky, A., Rodriguez, J. J., & Parpura, V. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1814-z · Cited by 68
Bradstreet, J. J., Sych, N., Antonucci, N., Klunnik, M., Ivankova, O., Matyashchuk, I., Demchuk, M., & Siniscalco, D. (2014) · Cell Transplantation · doi:10.3727/096368914x684916 · Cited by 68
Horvath, A., Łukasik, J., & Szajewska, H. (2017) · Journal of Nutrition · doi:10.3945/jn.116.242354 · Cited by 68
Bashir, S., & AL-Ayadhi, L. Y. (2013) · Pediatric Research · doi:10.1038/pr.2013.248 · Cited by 67
Cheng, Y.-S., Tseng, P.-T., Chen, Y.-W., Stubbs, B., Yang, W.-C., Chen, T.-Y., Wu, C.-K., & Lin, P.-Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s147305 · Cited by 67
Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease
Orsucci, D., Calsolaro, V., Mancuso, M., & Siciliano, G. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709788680689 · Cited by 66
Naltrexone and Communication Skills in Young Children With Autism
Feldman, H. M., Kolmen, B. K., & Gonzaga, A. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00021 · Cited by 65
Lynch, R., Diggins, E., Connors, S. L., Zimmerman, A. W., Singh, K., Liu, H., Talalay, P., & Fahey, J. W. (2017) · Global Advances in Health and Medicine · doi:10.1177/2164957x17735826 · Cited by 65
Vitamin D in the general population of young adults with autism in the faroe islands
Kočovská, E., Andorsdóttir, G., Weihe, P., Halling, J., Fernell, E., Stóra, T., Biskupstø, R., Gillberg, I. C., Shea, R., Billstedt, E., et al. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2155-1 · Cited by 64
Fleisher‐Berkovich, S., Abramovitch‐Dahan, C., Ben‐Shabat, S., Apte, R. N., & Beit‐Yannai, E. (2009) · Peptides · doi:10.1016/j.peptides.2009.04.003 · Cited by 64
Mostafa, G. A., & Al-Ayadhi, L. Y. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.12.010 · Cited by 64
A case report of naltrexone treatment of self-injury and social withdrawal in autism
Walters, A. S., Barrett, R. P., Feinstein, C., Mercurio, A., & Hole, W. T. (1990) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02284716 · Cited by 61
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome
Shenoy, S. M., Arnold, S., & Chatila, T. A. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105355 · Cited by 60
Bakheet, S. A., Alzahrani, M. Z., Nadeem, A., Ansari, M. A., Zoheir, K. M. A., Attia, S. M., AL-Ayadhi, L. Y., & Ahmad, S. F. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.09.004 · Cited by 60
A pilot open-label trial of minocycline in patients with autism and regressive features
Pardo, C. A., Buckley, A., Thurm, A., Lee, L.-C., Azhagiri, A., Neville, D. M., & Swedo, S. E. (2013) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-5-9 · Cited by 58
AL-Ayadhi, L. Y., & Mostafa, G. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-72 · Cited by 57
Behavioral Benefits of Camel Milk in Subjects with Autism Spectrum Disorder.
AL-Ayadhi, L. Y., Halepoto, D. M., Al-Dress, A. M., Mitwali, Y., & Zainah, R. (2015) · PubMed · Cited by 57
Mehrazad‐Saber, Z., Kheirouri, S., & Noorazar, S. G. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12979 · Cited by 57
Ghanizadeh, A. J., & Ayoobzadehshirazi, A. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.09.017 · Cited by 56
Ghaleiha, A., Alikhani, R., Kazemi, M.-R., Mohammadi, M.-R., Mohammadinejad, P., Zeinoddini, A., Hamedi, M., Shahriari, M., Keshavarzi, Z., & Akhondzadeh, S. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0175 · Cited by 55
The emerging roles of MicroRNAs in autism spectrum disorders
Fregeac, J., Colleaux, L., & Nguyen, L. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.018 · Cited by 54
Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders
Han, Y. M. Y., Cheung, W. K. Y., Wong, C. K., Sze, S. L., Cheng, T. W. S., Yeung, M. K., & Chan, A. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00011 · Cited by 54
Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy
Chez, M. G., & Guido-Estrada, N. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.008 · Cited by 53
Li, Y., Li, Y., & Xiang, D.-X. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1528-6 · Cited by 53
Melamed, I., Heffron, M., Testori, A., & Lipe, K. (2018) · Autism Research · doi:10.1002/aur.1906 · Cited by 53
Detection of IL-17 and IL-23 in Plasma Samples of Children with Autism
Enstrom, A., Onore, C., Hertz-Picc, I., Hansen, R., Croen, L., Water, J. V. D., & Ashwood, P. (2008) · American Journal of Biochemistry and Biotechnology · doi:10.3844/ajbbsp.2008.114.120 · Cited by 51
Pulte, E. D., Dmytrijuk, A., Nie, L., Goldberg, K. B., McKee, A. E., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0440 · Cited by 51
Hu, Y., Ehli, E. A., & Boomsma, D. I. (2017) · Autism Research · doi:10.1002/aur.1789 · Cited by 50
Carnosine: An Endogenous Neuroprotector in the Ischemic Brain
Stvolinsky, S. L., Kukley, M., Dobrota, D., Matejovičová, M., Tkáč, I., & Болдырев, А. А. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006960407008 · Cited by 48
Clinical effects of naltrexone on autistic behavior.
Zingarelli, G., Ellman, G., Hom, A., Wymore, M., Heidorn, S. D., & Chicz-DeMet, A. (1992) · PubMed · Cited by 48
Duffy, F. H., Shankardass, A., McAnulty, G. B., Eksioglu, Y. Z., Coulter, D., Rotenberg, A., & Als, H. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-70 · Cited by 48
Joshi, G., Wozniak, J., Faraone, S. V., Fried, R., Chan, J., Furtak, S., Grimsley, E., Conroy, K., Kilcullen, J. R., Woodworth, K. Y., et al. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000499 · Cited by 48
Hajizadeh-Zaker, R., Ghajar, A., Mesgarpour, B., Afarideh, M., Mohammadi, M.-R., & Akhondzadeh, S. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0026 · Cited by 47
N-acetylcysteine for treatment of autism, a case report.
Ghanizadeh, A. J., & Derakhshan, N. (2012) · PubMed Central · Cited by 46
Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients
El-Ansary, A. K., Hassan, W. M., Qasem, H., & Das, U. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164153 · Cited by 45
Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism
Tostes, M. H. F. D. S., Polonini, H. C., Gattaz, W. F., Raposo, N. R. B., & Baptista, E. B. (2012) · Trends in Psychiatry and Psychotherapy · doi:10.1590/s2237-60892012000300008 · Cited by 44
Fung, L. K., Libove, R. A., Phillips, J., Haddad, F., & Hardan, A. Y. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2144-4 · Cited by 43
Handen, B. L., Melmed, R. D., Hansen, R. L., Aman, M. G., Burnham, D. L., Bruss, J. B., & McDougle, C. J. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0687-y · Cited by 43
Effects of omega-3 fatty acids on serum levels of T-helper cytokines in children with asthma
Farjadian, S., Moghtaderi, M., Kalani, M., Gholami, T., & Teshnizi, S. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.002 · Cited by 41
Scifo, R., Cioni, M., Nicolosi, A., Batticane, N., Tirolo, C., Testa, N., Quattropani, M. C. A., Morale, M. C., Gallo, F., & Marchetti, B. (1996) · PubMed · Cited by 40
Bradstreet, J. J., Smith, S. A., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.015 · Cited by 40
Urbano, M., Okwara, L., Manser, P., Hartmann, K., & Deutsch, S. I. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13070155 · Cited by 39
Pro-inflammatory cytokines in autistic children in central Saudi Arabia
AL-Ayadhi, L. Y. (2005) · Neurosciences · doi:10.17712/1658-3183.1339 · Cited by 37
Buitelaar, J. K., van Engeland, H., van Ree, J. M., & de Wied, D. (1990) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02216053 · Cited by 37
Dialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study
Fudenberg, H. H. (1996) · Biotherapy · doi:10.1007/bf02628672 · Cited by 36
Therapeutic Role of Hematopoietic Stem Cells in Autism Spectrum Disorder-Related Inflammation
Siniscalco, D., Bradstreet, J. J., & Antonucci, N. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00140 · Cited by 35
Willemsen‐Swinkels, S. H. N., Buitelaar, J. K., van Berckelaer‐Onnes, I. A., & van Engeland, H. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1023000929040 · Cited by 34
Use of carnosine as a natural anti-senescence drug for human beings.
Wang, A. M., Ma, C., Xie, Z., & Shen, F. (2000) · PubMed · Cited by 34
Buitelaar, J. K., van Engeland, H., de Kogel, K. H., VRIES, H. D., van Hooff, J. A. R. A. M., & van Ree, J. M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90156-t · Cited by 33
Chantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., & Rubia, K. (2015) · Psychological Medicine · doi:10.1017/s0033291714002232 · Cited by 33
Anti-inflammatory Effect of Spironolactone on Human Peripheral Blood Mononuclear Cells
Miura, R., Nakamura, K., Miura, D., Miura, A., Hisamatsu, K., Kajiya, M., Nagase, S., Morita, H., KUSANO, K. F., Ohe, T., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.sc0060049 · Cited by 31
Change in Plasma Cytokine Levels During Risperidone Treatment in Children with Autism
Choi, J. E., Widjaja, F., Careaga, M., Bent, S., Ashwood, P., & Hendren, R. L. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0108 · Cited by 31
Cited by
Brain-body interactions underlying the association of loneliness with mental and physical health
Quadt, L., Esposito, G., Critchley, H. D., & Garfinkel, S. N. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.015 · Cited by 137
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 136
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 124
Trzmiel, T., Purandare, B., Michalak, M., Zasadzka, E., & Pawlaczyk, M. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.004 · Cited by 96
Chang, J. P., & Su, K. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.469 · Cited by 82
Metadata
- Authors
- Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 25
- Issue
- 5-6
- Pages
- 300-319
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2892087768
- Cited by
- 70
- References
- 236
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 4 · 2018: 3
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, immune dysfunction, immunomodulatory therapy, anti-inflammatory therapy, sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, luteolin, corticosteroids, intravenous immunoglobulin, oral immunoglobulin, cell therapy, minocycline, pioglitazone, risperidone, vitamin D, omega-3 fatty acids, Ginkgo biloba, L-carnosine, N-acetylcysteine, microbiota restoration, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Animals, Humans, Immunotherapy, Neuroimmunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.